Literature DB >> 20209481

A comparison of United States and United Kingdom EQ-5D health states valuations using a nonparametric Bayesian method.

Samer A Kharroubi1, Anthony O'Hagan, John E Brazier.   

Abstract

Cost-effectiveness analysis of alternative medical treatments relies on having a measure of effectiveness, and many regard the quality adjusted life year (QALY) to be the current 'gold standard.' In order to compute QALYs, we require a suitable system for describing a person's health state, and a utility measure to value the quality of life associated with each possible state. There are a number of different health state descriptive systems, and we focus here on one known as the EQ-5D. Data for estimating utilities for different health states have a number of features that mean care is necessary in statistical modelling.There is interest in the extent to which valuations of health may differ between different countries and cultures, but few studies have compared preference values of health states obtained from different countries. This article applies a nonparametric model to estimate and compare EQ-5D health state valuation data obtained from two countries using Bayesian methods. The data set is the US and UK EQ-5D valuation studies where a sample of 42 states defined by the EQ-5D was valued by representative samples of the general population from each country using the time trade-off technique. We estimate a utility function across both countries which explicitly accounts for the differences between them, and is estimated using the data from both countries. The article discusses the implications of these results for future applications of the EQ-5D and for further work in this field. Copyright 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20209481     DOI: 10.1002/sim.3874

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  11 in total

1.  Valuation of preference-based measures: can existing preference data be used to select a smaller sample of health states?

Authors:  Samer A Kharroubi; Donna Rowen
Journal:  Eur J Health Econ       Date:  2018-07-06

2.  Using the EuroQol EQ-5D in Swiss cancer patients, which value set should be applied?

Authors:  Klazien Matter-Walstra; Dirk Klingbiel; Thomas Szucs; Bernhard C Pestalozzi; Matthias Schwenkglenks
Journal:  Pharmacoeconomics       Date:  2014-06       Impact factor: 4.981

3.  Modelling a preference-based index for EQ-5D-3L and EQ-5D-3L + Sleep using a Bayesian framework.

Authors:  Samer A Kharroubi; Yara S Beyh; John Brazier; Yaling Yang
Journal:  Qual Life Res       Date:  2020-02-03       Impact factor: 4.147

4.  Valuing EQ-5D health states for Sri Lanka.

Authors:  Sanjeewa Kularatna; Jennifer A Whitty; Newell W Johnson; Ruwan Jayasinghe; Paul A Scuffham
Journal:  Qual Life Res       Date:  2014-12-28       Impact factor: 4.147

Review 5.  Is Meta-Analysis for Utility Values Appropriate Given the Potential Impact Different Elicitation Methods Have on Values?

Authors:  Tessa Peasgood; John Brazier
Journal:  Pharmacoeconomics       Date:  2015-11       Impact factor: 4.981

6.  Study protocol for valuing EQ-5D-3L and EORTC-8D health states in a representative population sample in Sri Lanka.

Authors:  Sanjeewa Kularatna; Jennifer A Whitty; Newell W Johnson; Paul A Scuffham
Journal:  Health Qual Life Outcomes       Date:  2013-09-02       Impact factor: 3.186

7.  Analysis of SF-6D Health State Utility Scores: Is Beta Regression Appropriate?

Authors:  Samer A Kharroubi
Journal:  Healthcare (Basel)       Date:  2020-12-01

8.  Swedish experience-based value sets for EQ-5D health states.

Authors:  Kristina Burström; Sun Sun; Ulf-G Gerdtham; Martin Henriksson; Magnus Johannesson; Lars-Åke Levin; Niklas Zethraeus
Journal:  Qual Life Res       Date:  2013-08-22       Impact factor: 4.147

9.  Bayesian nonparametric estimation of EQ-5D utilities for United States using the existing United Kingdom data.

Authors:  Samer A Kharroubi
Journal:  Health Qual Life Outcomes       Date:  2017-10-06       Impact factor: 3.186

10.  Valuation of preference-based measures: can existing preference data be used to generate better estimates?

Authors:  Samer A Kharroubi
Journal:  Health Qual Life Outcomes       Date:  2018-06-05       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.